About Inmune Bio (INMB)
INmune Bio Inc. operates as a clinical stage biotechnology company. The Company develops medicines to treat cancer. INmune Bio serves clients in the United States.
- USD7.35
- USD7.59
- USD7.15
- USD10.50
- -6.20%
- 0M
- 369.26k
- 271.89k
- 171M
- 4.32
- -23.70%
Stock News
yesterday
Trump doubles steel tariffs to 50%, touts U.S. Steel-Nippon deal still short on details
MarketWatch
yesterday
Taylor Swift now owns all her music thanks to her $2 billion Eras Tour
CNBC
yesterday
With Trump tariffs in limbo, the uncertainty is 'killing' us, business owner says: 'We need to know what things are going to cost'
CNBC
yesterday
Meta makes a big move into defense. Here's how it could start to matter for investors
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
